CARDINAL HEALTH: A Top Healthcare Company Delivering Pharmaceutical and Medical Goods to Over 30 Countries

Trending News ☀️

Cardinal Health ($NYSE:CAH) is a leading healthcare company that delivers pharmaceutical and medical goods to over 30 countries around the world. The company remains listed in the Fortune 500 and hired 46,500 employees globally in FY ’22. Cardinal Health has a diversified product portfolio that includes branded and generic drugs, medical devices, and over-the-counter products. In addition to its retail pharmacies, Cardinal Health also operates a number of mail order and specialty pharmacies.

Stock Price

The company has been in the news recently for its positive media exposure and strong financial performance. On Monday, CARDINAL HEALTH stock opened at $75.6 and closed at $75.2, down by 0.1% from prior closing price of 75.3. Despite the slight dip in stock price, the company remains a top healthcare company with a strong future outlook.

VI Analysis

The company’s cash flows and debt levels are strong, and it is capable of paying off debt and funding future operations. However, the company’s growth, profitability, and dividend are only average. Cardinal Health is classified as a ‘rhino’ company, which means that it has achieved moderate revenue or earnings growth. Investors interested in this company may be looking for a stable investment with a strong focus on fundamentals.

VI Peers

Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.

– AmerisourceBergen Corp ($NYSE:ABC)

AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.

– McKesson Corp ($NYSE:MCK)

McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.

– Sigma Healthcare Ltd ($ASX:SIG)

Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.

Summary

CARDINAL HEALTH is a top healthcare company that delivers pharmaceutical and medical goods to over 30 countries. Investing in CARDINAL HEALTH can provide you with a number of benefits, including the potential to generate significant profits. The company has a strong track record of delivering high-quality products and services, and its products are in high demand globally.

In addition, CARDINAL HEALTH has a strong financial position, with a strong balance sheet and healthy cash flow. As a result, investing in CARDINAL HEALTH can provide you with the potential for both short-term and long-term gain.